December 17 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its CEO Ognyan Donev has acquired 22,200 shares in the company at a weighted average price of 3.452 levs ($1.97/1.76 euro) per share.